ArticleCancer reports (Hoboken, N.J.)2025

Targeting the mTOR Signaling Pathway Through miR-100 and miR-101 in De Novo Acute Myeloid Leukemia: Implications for Therapeutic Intervention.

Maryam Kargar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.